In the specific case of this work, our data revealed important and novel aspects of motor neuron vulnerability associated with SYT13 and strengthened the idea that interventions aiming at increasing its expression in these specific cells might represent a valid therapeutic approach for motor neuron diseases such as SMA and ALS. The gene discussed is SYT13; the disease is proximal spinal muscular atrophy.